{"name":"Cyteir Therapeutics, Inc.","slug":"cyteir-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBScXRtQ0tnTHAtQ1RNeTQwUm9HcmNXWXVJUzg0NGo4b2dUVnVYSS01ekpBUlpXa1J0bDlpWlhham5ubzhYZXh4dW5yanlVR19ZSnc?oc=5","date":"2025-06-06","type":"trial","source":"Endpoints News","summary":"IPO Tracker (2021) - Endpoints News","headline":"IPO Tracker (2021)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNenh2T2dGNlRQekh5NjRkdnVpRXVDUC1Dams3WWU2OU5qU0dkZTJNOTFRR204VTZYS3oxaGp4UVdodmoxVjByZ3c3SUtvaDM1OWlkRGJTeWgwS2dTNGV0dUlFcWZETlVDS00tenE2YlItaklTLUxPaHRnalZaTzdGN1JFUGQyVy1jeHFKZjV2YzlRQnpkUEcyV0RzLVM4cVdUZ1NuNg?oc=5","date":"2025-02-28","type":"trial","source":"Endpoints News","summary":"Pfizer vet William Pao’s next venture; Sanofi’s computational science exec leaves - Endpoints News","headline":"Pfizer vet William Pao’s next venture; Sanofi’s computational science exec leaves","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOZUpMZHE3QTBQUFdIbEItcFVGZWJTOTlfMDFRM3M1cUVlZ0Ytb1FDVGNqMTRzRTVRZXBQSFcycWJDWVJoT2JpZURZRWxYNjJXbHdjaTJGeTI4TUNrLUtzbFY5VXhiSHhsajhaekZoTkdZdm5yYnJJZHM2THpVN0xMQ0cxbXhrWkxJV0NvV1laaU45T2lyWmFua0VIcTQ5YmNT?oc=5","date":"2025-02-25","type":"pipeline","source":"Fortune","summary":"Apple plans to hire 20,000 workers over the next four years but faces competition for AI talent - Fortune","headline":"Apple plans to hire 20,000 workers over the next four years but faces competition for AI talent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPTnlRUk1sYUwxQ0wzcFpWVmZPZl9aQ3l3MUtiSEVsdTJLUkE2Wk5BajFoU0ZzUzE5UW9mUGhoMGMtQ0FSZjZDMGdWN2pyT2twbGVmSUQxZk13T191TnBjY0NnY01BVjQwUmtkemRWRDBHMHFCVjByUlNXY0VqOXJ5SXRYLUltYVlUamQ0NnpLamRiam5xMU0xZnc5V1YxOGZxNi1Jd1hSOVRDemtqdWM3UUpqT21JZjFhcFE?oc=5","date":"2025-02-24","type":"pipeline","source":"Stock Titan","summary":"Can This Former Amgen VP Transform Terns Pharmaceuticals as New CFO? - Stock Titan","headline":"Can This Former Amgen VP Transform Terns Pharmaceuticals as New CFO?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1Vc3dPUHN6aUotY29XVHVGQmt1U1FvWUQ0S0ZDUUxFVkxyaGxmblFnOHFSdTBXYjgySnBDcnAzR3lKTl8wUk1HNmV5Vl9UQ0dOc3hn?oc=5","date":"2025-01-09","type":"pipeline","source":"FirstWord Pharma","summary":"New biotech Light Horse snags $1B+ Novartis pact on launch day - FirstWord Pharma","headline":"New biotech Light Horse snags $1B+ Novartis pact on launch day","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQZFg5cW5IcS1BWFAySEJ4X3NDdmtKVWs5dkVBcTJtVlRqRWl4RjRuc25sblZWTThUR0ZWTDdYZk1ZU0xIR25qQTNZNnBHOVQ1eW84RThlT3R6enJhOWo0MVhSalR3LTZYdTZlbDdoUnktNHdYY01PLVhwMnFzanJZX2M4anQ?oc=5","date":"2024-04-24","type":"deal","source":"Pharmaceutical Technology","summary":"Incyte signs deal to acquire Escient Pharmaceuticals - Pharmaceutical Technology","headline":"Incyte signs deal to acquire Escient Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQS2VwbHc2UlFvQVdMQUYzczYwdm50LTRpZjVuRDZLQURtU0hZYy1kY2RJUVhUeFZiRklXTEZtMmZsQ2pENnptUlphY2JKQUlzV3FXb3JOS2xjdW1mVS0xRWlCWmgxbC1qQktoM2t4aWNzd3hxQk8wTm5nQmhPT04yT2NMUVotWmlSc0dqb25OUVhOYWVoTGpkMWdoMVp5Z3JUYTBiSkRyakhXaUVfNjJWWG1WeDZJOXVWeERObg?oc=5","date":"2024-03-07","type":"pipeline","source":"businesswire.com","summary":"Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq - businesswire.com","headline":"Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNWU5WNWVCRG1DRjFYWGZRZWFYaXppZFVBZnJtTEVnb1M2RG9WM29OV0laR2Rac2FjRmItYVBwWG5MczFKam84RGNZZXJlbVlEZnNJVThjd1M5NFB3amdBQkMyZGtzbUdJUlYxVmc3UnJobTV1R1d2dnFKNm9mSk1lRTROb1dNY1dPdnRmWW8wLWtYTE9u?oc=5","date":"2024-01-02","type":"pipeline","source":"The Business Journals","summary":"The definitive Boston biotech layoff tracker for 2023 - The Business Journals","headline":"The definitive Boston biotech layoff tracker for 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPQ2pTR2VodE8yVlAtWExMTmtKTzZDRXJDdGJOcHVKTmRrbWliVnk5SmhaYVpxckFDeHhNR3l2eHB5Nk5xZVBiRGlES2U0RFdTcjJSQVNGVFhSRkxYdktqUnotcFRqUmtjczlFT1Q1XzFUeFNPTUJJaWd0ME5WQTN6TnhVZWNqeDNMejdwdmZR?oc=5","date":"2023-06-30","type":"pipeline","source":"Fierce Biotech","summary":"Cyteir finally calls it quits after months of cost cutting - Fierce Biotech","headline":"Cyteir finally calls it quits after months of cost cutting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxQQ1JabHVBYWdIaklwLTJ3VkxHTVBON3Z5N09reVREdmJlTFI3RDB3SWZSLWEzSnBNTkZkMXB2QzktQW0xcHVFTnp6OTEwYjRBTjJOa2NqTGxWdklEYWRmTG1iclNoQUJNeFMtNmZlaE5VOVc0Vnk4aDduX0swRjFyTEZlaGJWUzh3dEc2czZzUk45XzdiWWJqMnRZUjBON0ppSG9CY1FsWk51TmFkV0s4X3RZYUVfSC1FNHNuQlVYcUloNnZobjJUdjBGSXR2U2JmbWZYZTlaYk9PYzRJa0ZJLTlOWExrMDB0WDNzclp3aUNUemx4UFZLTzcwZ1RwazZRZ3AtQQ?oc=5","date":"2023-06-30","type":"pipeline","source":"businesswire.com","summary":"Cyteir Therapeutics Announces Discontinuation of CYT-0851 Development Program and Planned Liquidation and Dissolution - businesswire.com","headline":"Cyteir Therapeutics Announces Discontinuation of CYT-0851 Development Program and Planned Liquidation and Dissolution","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOaUlEcWtGVlNNd3RGQWJTaDJKXzVyakNSQnVGVjJOYVMtalZwTFdaVHliUlRlc2VmZEwyZmc4Rk9WRWNrYVhlRzc3Rnk3RDd6TUgxODV6Ukd1My1MeTExMjV2T3NVcUdqYUJpWEJ1Vm9MWTRUQ3hNN2E4QzhocnlTUUhBLXRMd3p4ZzVDVlFOb2ZTb2R6TUdVWERBZks5QkU?oc=5","date":"2023-05-11","type":"pipeline","source":"Fierce Biotech","summary":"Fusion, Cyteir refocus pipelines to funnel cash toward best bets - Fierce Biotech","headline":"Fusion, Cyteir refocus pipelines to funnel cash toward best bets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxObHI2Z1VoRDV6bDZIMHgyZVppS0ZFNHNETWtvRTRiVzZ1RXRtWS1NcTdLeGtGNGZIQ0QtampyTmUtQ0N1XzRfdWgwWW95aFhCdEhKVzk5WXBmRzlhczMtUVdtYTJ0dmY5Ui1rYlYzRElWNlp1RUFUMUN6S3lXNWlDa3ZmQ2tpYlRNYkFFMHFoNVZVS1lUR0JweGNSMGFiTHpKaF9WMzlSQksydw?oc=5","date":"2021-10-14","type":"pipeline","source":"The Business Journals","summary":"How newly public firms responded to questions on diversity - The Business Journals","headline":"How newly public firms responded to questions on diversity","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}